Adding weekly irinotecan to high-dose 5-fluorouracil and folinic acid (HD-5-FU/FA) after failure for first-line HD-5-FU/FA in advanced colorectal cancer - a phase II study - Hofheinz, Ralf-Dieter; Hartung, Gernot; Samel, Stefan; Emig, Michael; Pilz, Lothar R.; Willeke, Frank; Hochhaus, Andreas; Hehlmann, Rüdiger; Queißer, Wolfgang (Anti-cancer drugs, 2002)
Gesehen am 16.05.2022